← Scroll for more →
Financial Statements — ADSE
Balance Sheet
(in millions EUR)| Metric | Q2 2025 | Q4 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q4 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 37.87 | 22.86 | 29.16 | 0.01 | 34.44 | 101.81 |
| Inventory | 72.21 | 77.66 | -- | -- | -- | -- |
| Total Current Assets | 104.66 | 115.04 | 89.51 | 0.10 | 105.25 | 127.15 |
| Total Non-current Assets | 28.44 | 30.19 | 34.90 | 0.03 | 34.19 | 24.07 |
| Total Assets | 133.10 | 145.23 | 124.41 | 0.14 | 139.44 | 151.22 |
| Total Current Liabilities | 55.27 | 61.85 | 60.35 | 0.06 | 42.37 | 30.44 |
| Total Non-current Liabilities | 92.75 | 126.19 | 30.14 | 0.03 | 16.32 | 23.89 |
| Total Liabilities | 148.01 | 188.04 | 90.49 | 0.08 | 58.70 | 54.33 |
| Retained Earnings | (289.16) | (191.20) | (136.12) | (0.14) | -- | -- |
| Total Stockholder Equity | (14.91) | (42.81) | 33.92 | 0.05 | 80.75 | 96.89 |
← Scroll for more columns →
Income Statement
(in millions EUR) (except per-share rows)| Metric | Q2 2025 | Q4 2023 | Q2 2023 |
|---|---|---|---|
| Total Revenue | 14.61 | -- | 0.04 |
| Cost of Revenue* | 21.28 | -- | 0.04 |
| Gross Profit | (6.66) | 10.00 | -0.00 |
| Research & Development | 4.47 | -- | 0.00 |
| Selling, General & Admin | 18.62 | -- | 0.02 |
| Total Operating Expenses* | 23.35 | -- | 0.02 |
| Operating Income | (30.01) | -- | (0.02) |
| Pretax Income | (14.88) | -- | (0.03) |
| Tax Provision | (0.12) | -- | -0.00 |
| Basic EPS | (0.27) | -- | (0.59) |
| Diluted EPS | (0.27) | -- | (0.59) |
← Scroll for more columns →
* Derived from reported values
Cash Flow Statement
(in millions EUR)| Metric | Q2 2025 | Q2 2023 |
|---|---|---|
| Operating Cash Flow | (30.20) | (0.03) |
| Investing Cash Flow | (1.01) | -0.00 |
| Financing Cash Flow | 46.38 | 0.01 |
← Scroll for more columns →